"mRNA Vaccines"[MeSH Terms] - Search Results

Year	Number of Results
2019	2
2020	42
2021	1632
2022	2961
2023	1441
2024	403

1

Ramachandran S, Satapathy SR, Dutta T. Ramachandran S, et al. Pharmaceut Med. 2022 Feb;36(1):11-20. doi: 10.1007/s40290-021-00417-5. Epub 2022 Jan 30. Pharmaceut Med. 2022. PMID: 35094366 Free PMC article. Review.

2

Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273.

Teo SP. Teo SP. J Pharm Pract. 2022 Dec;35(6):947-951. doi: 10.1177/08971900211009650. Epub 2021 Apr 12. J Pharm Pract. 2022. PMID: 33840294 Review.

3

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.

Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Fiolet T, et al. Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27. Clin Microbiol Infect. 2022. PMID: 34715347 Free PMC article. Review.

4

mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.

Le T, Sun C, Chang J, Zhang G, Yin X. Le T, et al. Viruses. 2022 Feb 15;14(2):401. doi: 10.3390/v14020401. Viruses. 2022. PMID: 35215994 Free PMC article. Review.

5

Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8⁺ T cell response.

Chen J, Ye Z, Huang C, Qiu M, Song D, Li Y, Xu Q. Chen J, et al. Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2207841119. doi: 10.1073/pnas.2207841119. Epub 2022 Aug 15. Proc Natl Acad Sci U S A. 2022. PMID: 35969778 Free PMC article.

6

Principles for designing an optimal mRNA lipid nanoparticle vaccine.

Kon E, Elia U, Peer D. Kon E, et al. Curr Opin Biotechnol. 2022 Feb;73:329-336. doi: 10.1016/j.copbio.2021.09.016. Epub 2021 Oct 26. Curr Opin Biotechnol. 2022. PMID: 34715546 Free PMC article. Review.

7

Role of COVID-19 Vaccines in SARS-CoV-2 Variants.

Zhou Z, Zhu Y, Chu M. Zhou Z, et al. Front Immunol. 2022 May 20;13:898192. doi: 10.3389/fimmu.2022.898192. eCollection 2022. Front Immunol. 2022. PMID: 35669787 Free PMC article. Review.

8

Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic.

Jain S, Venkataraman A, Wechsler ME, Peppas NA. Jain S, et al. Adv Drug Deliv Rev. 2021 Dec;179:114000. doi: 10.1016/j.addr.2021.114000. Epub 2021 Oct 9. Adv Drug Deliv Rev. 2021. PMID: 34637846 Free PMC article. Review.

9

A Bivalent Omicron-Containing Booster Vaccine against Covid-19.

Chalkias S, Harper C, Vrbicky K, Walsh SR, Essink B, Brosz A, McGhee N, Tomassini JE, Chen X, Chang Y, Sutherland A, Montefiori DC, Girard B, Edwards DK, Feng J, Zhou H, Baden LR, Miller JM, Das R. Chalkias S, et al. N Engl J Med. 2022 Oct 6;387(14):1279-1291. doi: 10.1056/NEJMoa2208343. Epub 2022 Sep 16. N Engl J Med. 2022. PMID: 36112399 Free PMC article. Clinical Trial.

10

mRNA-Based Vaccines and Mode of Action.

Gergen J, Petsch B. Gergen J, et al. Curr Top Microbiol Immunol. 2022;440:1-30. doi: 10.1007/82_2020_230. Curr Top Microbiol Immunol. 2022. PMID: 33591423 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

5,710 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

5,710 results

Results by year